Obsessive Compulsive Disorder clinical trials
Showing 51–72 of 72 active trials. Describe your situation to see which ones you may be eligible for.
- Modulating Anxious Coping
- Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
- Modulating Escape Using Focused Ultrasound
- rTMS Device for Improvement of Obsessive and Compulsive Behaviors
- Precision Brain Mapping to Predict and Track Response to Exposure and Response Prevention Therapy in Youth With Obsessive-Compulsive Disorder
- Sonication-based OCD Neurosurgical Intervention Via Capsulotomy
- Psilocybin for Treatment of OCD-2
- Digital Coach to Support Exposure Therapy Homework for Anxious Youth
- The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens
- Connectomic Targeted TMS Target for Refractory Anxiety
- Locating Biomarkers in OCD Through Behavioral Tasks
- Role of Theta Frequency Oscillations in Proactive and Reactive Control Processes in Youth With Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD)
- Neurobehavioral Investigations of Approach Dynamics in the Ventral Striatum
- Can Computational Measures of Task Performance Predict Psychiatric Symptoms and Changes in Symptom Severity Across Time
- Accelerated TMS for Depression and OCD
- Ventral Capsulotomy for Intractable OCD
- Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
- Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models
- Personalized DBS for OCD Guided by Stereoencephalography Mapping
- Using Personalized Assessments in the Treatment of Childhood OCD
- Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
- Discovering Factors in the Clinical Study Journey of Patients With OCD
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.